Gökbuget, N., Kelsh, M., Chia, V., Advani, A., Bassan, R., Dombret, H., . . . Kantarjian, H. (2016). Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. Nature Publishing Group.
Chicago Style CitationGökbuget, N., et al. Blinatumomab Vs Historical Standard Therapy of Adult Relapsed/refractory Acute Lymphoblastic Leukemia. Nature Publishing Group, 2016.
MLA CitationGökbuget, N., et al. Blinatumomab Vs Historical Standard Therapy of Adult Relapsed/refractory Acute Lymphoblastic Leukemia. Nature Publishing Group, 2016.
Warning: These citations may not always be 100% accurate.